Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in August

...ANCISCO, Calif., July 29 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...te at http://www.poniard.com . About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer

...atic Castration-Resistant Prostate Cancer - - poniard Management Team to Host Analyst and Investor Brief...RANCISCO, Calif., May 28 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...r cancers." Analyst and Investor Briefing poniard will host an investor event in Orlando on Sunday, ...

Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability

...if. and DENVER, April 21 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...atients, whose therapeutic options become limited. poniard is currently evaluating an intravenous formulation...nations and by two routes of administration. poniard is currently evaluating the efficacy and safety of...

Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology

...NCISCO, Calif., April 20 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...latinum-refractory and -resistant patients. poniard is currently evaluating the efficacy and safety of...ase 1 clinical trial in solid tumors. About poniard Pharmaceuticals ...

Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization

...NCISCO, Calif., March 20 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...uild shareholder value. I would like to thank the poniard employees who have been affected by this change fo...icant contributions to the Company." About poniard Pharmaceuticals ...

Poniard Pharmaceuticals to Present at Needham & Company's Cancer Therapeutics: Today & Tomorrow Conference

...NCISCO, Calif., March 19 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar... website at http://www.poniard.com . About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard Pharmaceuticals Receives Going Concern Qualification

...NCISCO, Calif., March 16 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...e fiscal year ended December 31, 2008. About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs

...ation, in Seattle, Washington, (an organization currently doing business as poniard Pharmaceuticals). poniard is a publicly traded biotech company developing small-molecule drugs and ta...

Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer

...ANCISCO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar... biotech and healthcare industry, which will serve poniard well as we continue our efforts to advance picopla...ur commercial strategy." Mr. Weaver brings to poniard more than 17 years of experience in executive fina...

Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin

...oplatin as a franchise product worldwide." poniard plans to work toward the achievement of the follow...ombinations and in two formulations. About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard in Medical Technology

Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

...ANCISCO, Calif., July 21 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...d with other platinum chemotherapy drugs. poniard is currently evaluating the efficacy and safety of...enter, randomized, controlled trial in March 2009. poniard is also evaluating picoplatin in a Phase 2 clinica...

Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer

...First-Line Treatment of Colorectal Cancer - - poniard Management Team to Host Analyst and Investor Brief...RANCISCO, Calif., May 28 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...l cancer." Analyst and Investor Briefing poniard will host an investor event in Orlando on Sunday, ...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

...FRANCISCO, Calif., May 5 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...pipeline in a product. Such partner would provide poniard co-development and co-promotion rights in the U.S.... Small Cell Lung Cancer In March, poniard reached its enrollment target and a total of 401 p...

Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology

...FRANCISCO, Calif., May 4 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ) today anno... Eastern Time, Level 2, West Hall E1 poniard Investor Event In addition to the picoplatin posters and presentation, poniard will host an investor event, in Orlando, on Sunday...

Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer

...NCISCO, Calif., March 25 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...ocol Assessment (SPA) developed with the FDA. poniard has received Orphan Drug and Fast Track designatio...ase 1 clinical trial in solid tumors. About poniard Pharmaceuticals ...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

...NCISCO, Calif., March 16 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar... Prostate Cancer: In February 2009, poniard presented updated efficacy and safety data from it... Commercial Product Supply: In November, poniard announced an agreement with Baxter Oncology GmbH f...

Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin

...g, colorectal and prostate cancers." About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...currence of unanticipated events. (C) 2008 poniard Pharmaceuticals, Inc. All Rights Reserved. ...

Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin

... No myelosuppression occurred after oral dosing. poniard expects to present additional data from the trial ...observed with other platinum chemotherapy drugs. poniard is evaluating intravenous picoplatin in an ongoing...ny regulatory authority for use in humans. About poniard Pharmaceuticals ...

Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer

...lif. and CHICAGO, June 1 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharm...observed with other platinum chemotherapy drugs. poniard is evaluating intravenous picoplatin in an ongoing...ny regulatory authority for use in humans. About poniard Pharmaceuticals ...

Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer

...lif. and CHICAGO, June 1 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharm...tion to the ongoing Phase 2 clinical trial in CRC, poniard is evaluating intravenous picoplatin in an ongoing...ny regulatory authority for use in humans. About poniard Pharmaceuticals ...

Poniard in Biological Technology

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...RANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...been and will continue to serve as a consultant to poniard on matters of corporate and business development a...hange Commission on June 2, 2009. This will allow poniard from time to time to offer and sell up to $60 mill...

Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4

...SAN FRANCISCO, July 28 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...the Company's Web site for 10 days. About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors

...RANCISCO, Calif., July 9 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...pointment increases the number of directors on the poniard board to ten. "We are pleased Gary is on the ...usiness." "I look forward to working with the poniard board and management team to successfully implemen...

Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference

...RANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...site at http://www.poniard.com . About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard Pharmaceuticals Files Shelf Registration

...RANCISCO, Calif., May 15 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...at, when declared effective by the SEC, will allow poniard from time to time to offer and sell up to $60 mill...ditions and the Company's future financing needs. poniard intends to use the proceeds from the sale of any s...

Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference

...RANCISCO, Calif., May 13 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...site at http://www.poniard.com . About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard Pharmaceuticals to Present at the 2009 BIO International Convention

...RANCISCO, Calif., May 12 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...ze the value of picoplatin worldwide." About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer

...FRANCISCO, Calif., May 5 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ) today anno...s and by two routes of administration. About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...

Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer

...if. and DENVER, April 21 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar...romising clinical activity observed in this trial, poniard initiated a randomized, controlled, proof-of-conce... In addition to the Phase 2 clinical trial in CRC, poniard is currently evaluating the efficacy and safety of...

Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Research's 100th Annual Meeting

...NCISCO, Calif., April 14 /PRNewswire-FirstCall/ -- poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biophar... 12 Hall B-F, Poster Section 31 About poniard Pharmaceuticals poniard Pharmaceuticals, Inc. is a biopharmaceutical compa...